Degranulation of cytotoxic NK cells was measured to investigate if potential impairments in intracellular signalling through ERK1/2 contribute to reduced cytotoxic activity in CFS/ME patients. The gene discussed is MAPK3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.